Category: Papers

CDK8_image_thumbnail
Read more
NewsPapers

Acute lymphoblastic leukemia: new class of “dual-action” drug for cancer treatment

RecentPaper_cm
Read more
NewsPapers

New insights into the development of an unusual childhood disease

RecentPaper_cm
Read more
NewsPapers

A molecular switch to high-revving innate immunity

Read more
NewsPapers

How the structure of STAT5B turns a normal cell into a cancer cell

Read more
NewsPapers

New treatment option for leukemia

Read more
NewsPapers

STAT1 and myeloid cells – a mutual interplay in blood cell formation outside of the bone marrow and in early antiviral defence

Read more
NewsPapers

Natural killer (NK) cells differentially require TYK2 for fighting tumours and bacterial infections

Gorki_thumbnail
Read more
NewsPapers

New treatment approach against leukemia

Read more
NewsPapers

Unravelling the molecular mechanisms behind transmissibility of cancer in Tasmanian devils

14_01_2019_ContagiousCancer_thumbnail2
Read more
NewsPapers

Contagious Cancer in the Tasmanian Devil: Molecular Mechanisms Decoded

21_12_2018_twoPublications_thumbnail
Read more
AwardsNews

Two publications from the Institute of Pharmacology and Toxicology receive awards

Read more
NewsPapers

The Janus Kinase JAK1 impacts on Natural Killer (NK) cell functions

Read more
NewsPapers

STAT1’s shorter beta isoform recruits gene-specifically different components of the transcription machinery

Read more
NewsPapers

DDX3X – a determinant of gender differences in innate immunity?

03_09_2018_anaplasticLargeCellLymphoma_thumbnail
Read more
NewsPapers

Survival signalling mediated by Tyk2 is the Achilles’ heel of Anaplastic Large Cell Lymphomas

RecentPaper_cm
Read more
NewsPapers

Increased anti-tumor activity of natural killer cells thanks to the loss of CDK8

Read more
NewsPapers

New strategy to target transcription factor STAT5 to combat leukaemia

22_02_2018_Thumbnail
Read more
NewsPapers

New strategy against acute myeloid leukemia through inhibition of STAT5 transcription